Search
Fenclofenac
go.drugbank.com/drugs/DB21391ExperimentalFenclofenac has a monoisotopic molecular weight of 296.0 Da. … Fenclofenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Fenclofenac is a anti-inflammatory agent, ibufenac derivative.
Pirinidazole
go.drugbank.com/drugs/DB21413ExperimentalPirinidazole has a monoisotopic molecular weight of 250.05 Da. … Pirinidazole is a small molecule drug. The usage of the INN stem '-nidazole' in the name indicates that Pirinidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.
Tifurac
go.drugbank.com/drugs/DB21415ExperimentalTifurac has a monoisotopic molecular weight of 326.06 Da. … Tifurac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Tifurac is a anti-inflammatory agent, ibufenac derivative.
Pilavapadin
go.drugbank.com/drugs/DB21552InvestigationalPilavapadin has a monoisotopic molecular weight of 385.18 Da. … Pilavapadin is a small molecule drug. Pilavapadin is under investigation in clinical trial NCT06203002 (A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)).
Canocapavir
go.drugbank.com/drugs/DB21570ExperimentalCanocapavir has a monoisotopic molecular weight of 561.08 Da. … Canocapavir is a small molecule drug. The usage of the INN stem '-capavir' in the name indicates that Canocapavir is a viral capsid and nucleocapsid inhibitor.
Emzeltrectinib
go.drugbank.com/drugs/DB21605ExperimentalEmzeltrectinib has a monoisotopic molecular weight of 376.13 Da. … Emzeltrectinib is a small molecule drug. The usage of the INN stem '-trectinib' in the name indicates that Emzeltrectinib is a tropomyosin receptor kinase (TRK) inhibitor.
Zavondemstat
go.drugbank.com/drugs/DB21608ExperimentalZavondemstat has a monoisotopic molecular weight of 431.22 Da. … Zavondemstat is a small molecule drug. The usage of the INN stem '-demstat' in the name indicates that Zavondemstat is a Lysine-specific histone demethylase inhibitor.
Levamlodipine
go.drugbank.com/drugs/DB09237ApprovedInvestigational[A188940] Levamlodipine was granted FDA approval on 19 December 2019.[L10833] … [L10833] This medication was first marketed in Russia and India before being granted FDA approval.